BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23005029)

  • 21. Applications of graphene-based nanomaterials in drug design: The good, the bad and the ugly.
    Gao Z; Qin S; Ménard-Moyon C; Bianco A
    Expert Opin Drug Discov; 2023; 18(12):1321-1332. PubMed ID: 37661858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular localization and toxicity of graphene oxide and reduced graphene oxide nanoplatelets to mussel hemocytes in vitro.
    Katsumiti A; Tomovska R; Cajaraville MP
    Aquat Toxicol; 2017 Jul; 188():138-147. PubMed ID: 28521151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functionalized graphene oxide as a vehicle for targeted drug delivery and bioimaging applications.
    Karki N; Tiwari H; Tewari C; Rana A; Pandey N; Basak S; Sahoo NG
    J Mater Chem B; 2020 Sep; 8(36):8116-8148. PubMed ID: 32966535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of the applications of organo-functionalized magnetic graphene oxide nanocomposites for heavy metal adsorption.
    Sherlala AIA; Raman AAA; Bello MM; Asghar A
    Chemosphere; 2018 Feb; 193():1004-1017. PubMed ID: 29874727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the toxicity of graphene oxide exposure to the eye.
    Wu W; Yan L; Wu Q; Li Y; Li Q; Chen S; Yang Y; Gu Z; Xu H; Yin ZQ
    Nanotoxicology; 2016 Nov; 10(9):1329-40. PubMed ID: 27385068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functionalized graphene oxide as a nanocarrier for dual drug delivery applications: The synergistic effect of quercetin and gefitinib against ovarian cancer cells.
    Tiwari H; Karki N; Pal M; Basak S; Verma RK; Bal R; Kandpal ND; Bisht G; Sahoo NG
    Colloids Surf B Biointerfaces; 2019 Jun; 178():452-459. PubMed ID: 30921680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomedical applications of the graphene-based materials.
    Zhang B; Wang Y; Zhai G
    Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():953-64. PubMed ID: 26838925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing biocompatibility of graphene oxide-based nanocarriers: A review.
    Kiew SF; Kiew LV; Lee HB; Imae T; Chung LY
    J Control Release; 2016 Mar; 226():217-28. PubMed ID: 26873333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acoustic cavitation induced generation of stabilizer-free, extremely stable reduced graphene oxide nanodispersion for efficient delivery of paclitaxel in cancer cells.
    Geetha Bai R; Muthoosamy K; Shipton FN; Manickam S
    Ultrason Sonochem; 2017 May; 36():129-138. PubMed ID: 28069192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy.
    Ma N; Liu J; He W; Li Z; Luan Y; Song Y; Garg S
    J Colloid Interface Sci; 2017 Mar; 490():598-607. PubMed ID: 27923144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surface coating-dependent cytotoxicity and degradation of graphene derivatives: towards the design of non-toxic, degradable nano-graphene.
    Li Y; Feng L; Shi X; Wang X; Yang Y; Yang K; Liu T; Yang G; Liu Z
    Small; 2014 Apr; 10(8):1544-54. PubMed ID: 24376215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Graphene oxide: An efficient material and recent approach for biotechnological and biomedical applications.
    Singh DP; Herrera CE; Singh B; Singh S; Singh RK; Kumar R
    Mater Sci Eng C Mater Biol Appl; 2018 May; 86():173-197. PubMed ID: 29525091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzymatically cross-linked hyaluronic acid/graphene oxide nanocomposite hydrogel with pH-responsive release.
    Song F; Hu W; Xiao L; Cao Z; Li X; Zhang C; Liao L; Liu L
    J Biomater Sci Polym Ed; 2015; 26(6):339-52. PubMed ID: 25598448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promises, facts and challenges for graphene in biomedical applications.
    Reina G; González-Domínguez JM; Criado A; Vázquez E; Bianco A; Prato M
    Chem Soc Rev; 2017 Jul; 46(15):4400-4416. PubMed ID: 28722038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted Delivery of Docetaxel by Use of Transferrin/Poly(allylamine hydrochloride)-functionalized Graphene Oxide Nanocarrier.
    Nasrollahi F; Varshosaz J; Khodadadi AA; Lim S; Jahanian-Najafabadi A
    ACS Appl Mater Interfaces; 2016 Jun; 8(21):13282-93. PubMed ID: 27158834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dispersed graphene materials of biomedical interest and their toxicological consequences.
    Patil R; Bahadur P; Tiwari S
    Adv Colloid Interface Sci; 2020 Jan; 275():102051. PubMed ID: 31753296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Graphene oxide and creatine phosphate disodium dual template-directed synthesis of GO/hydroxyapatite and its application in drug delivery.
    Yao C; Zhu J; Xie A; Shen Y; Li H; Zheng B; Wei Y
    Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():709-715. PubMed ID: 28183664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of graphene-based nanomaterial as nanocarrier for adsorption of paclitaxel anticancer drug: a molecular dynamics simulation study.
    Hasanzade Z; Raissi H
    J Mol Model; 2017 Feb; 23(2):36. PubMed ID: 28120117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systems toxicology approach reveals the Wnt-MAPK crosstalk pathway mediated reproductive failure in Caenorhabditis elegans exposed to graphene oxide (GO) but not to reduced graphene oxide (rGO).
    Chatterjee N; Kim Y; Yang J; Roca CP; Joo SW; Choi J
    Nanotoxicology; 2017 Feb; 11(1):76-86. PubMed ID: 27901397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nano graphene oxide: a novel carrier for oral delivery of flavonoids.
    Rahmanian N; Hamishehkar H; Dolatabadi JE; Arsalani N
    Colloids Surf B Biointerfaces; 2014 Nov; 123():331-8. PubMed ID: 25282100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.